Drug Profile
Arketamine - Jiangsu Hengrui Medicine
Alternative Names: HR 071603; Hydrochloric Acid (R) - Ketamine Nasal Spray - Jiangsu Hengrui Medicine; Ketamine Nasal Spray - Jiangsu Hengrui Medicine; R-ketamine - Jiangsu Hengrui MedicineLatest Information Update: 28 Nov 2022
Price :
$50
*
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Analgesics; Antidepressants; Behavioural disorder therapies; Chlorobenzenes; Cyclohexanones; Small molecules
- Mechanism of Action AMPA receptor agonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Depressive disorders
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for phase-I development in Depressive disorders(In volunteers) in China (Intranasal, Spray)
- 01 Jun 2021 Jiangsu HengRui Medicine completes a phase I trial in Depressive disorders (In volunteers) in China (Intranasal) (NCT04108234)
- 17 Oct 2019 Chemical structure information added